| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0527-4592-13 | 0527-4592 | HUMAN PRESCRIPTION DRUG | Oseltamivir Phosphate | oseltamivir phosphate | CAPSULE | ORAL | 20230515 | N/A | ANDA | ANDA212739 | Lannett Company, Inc. | OSELTAMIVIR PHOSPHATE | 45 mg/1 | 1 BLISTER PACK in 1 CARTON (0527-4592-13) / 10 CAPSULE in 1 BLISTER PACK |
| 0527-4593-13 | 0527-4593 | HUMAN PRESCRIPTION DRUG | Oseltamivir Phosphate | oseltamivir phosphate | CAPSULE | ORAL | 20230515 | N/A | ANDA | ANDA212739 | Lannett Company, Inc. | OSELTAMIVIR PHOSPHATE | 75 mg/1 | 1 BLISTER PACK in 1 CARTON (0527-4593-13) / 10 CAPSULE in 1 BLISTER PACK |
| 50090-7347-0 | 50090-7347 | HUMAN PRESCRIPTION DRUG | Oseltamivir Phosphate | oseltamivir phosphate | CAPSULE | ORAL | 20241016 | N/A | ANDA | ANDA212739 | A-S Medication Solutions | OSELTAMIVIR PHOSPHATE | 75 mg/1 | 1 BLISTER PACK in 1 CARTON (50090-7347-0) / 10 CAPSULE in 1 BLISTER PACK |
| 0527-4591-13 | 0527-4591 | HUMAN PRESCRIPTION DRUG | Oseltamivir Phosphate | oseltamivir phosphate | CAPSULE | ORAL | 20230515 | N/A | ANDA | ANDA212739 | Lannett Company, Inc. | OSELTAMIVIR PHOSPHATE | 30 mg/1 | 1 BLISTER PACK in 1 CARTON (0527-4591-13) / 10 CAPSULE in 1 BLISTER PACK |